Limbix Spark is the first prescription digital therapeutic designed to support adolescents with depression. Spark is a multi-week cognitive behavioral therapy based program focused on the completion of value-based activities that spark feelings of pleasure or mastery. Later in 2020 Limbix Spark will be publicly available as part of a real-world evidence clinical trial.
COVID-19 use cases:
Limbix Spark includes behavioral activations that have been modified to be appropriate activities post COVID-19.
AVIA Marketplace is where innovative health systems and hospitals go to find the right digital health solutions. It’s built to efficiently search vendors and guide informed decisions, with tools like product comparisons, match scores, report generators, peer reviews, and market insights.
AVIA Marketplace is brought to you by AVIA, a trusted company and community of experts who guide health systems on their digital transformation journey.
Stay up to date
Keep up with the latest products and trends in digital health.